BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22664782)

  • 41. [Effect of danhong injection on ET-1, sP-sel, and hs-CRP in patients with acute coronary syndrome undergoing percutaneous coronary intervention].
    Zhao PX; Jiang S
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Jan; 31(1):11-4. PubMed ID: 21434335
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gene expression profiling reveals multiple differences in platelets from patients with stable angina or non-ST elevation acute coronary syndrome.
    Colombo G; Gertow K; Marenzi G; Brambilla M; De Metrio M; Tremoli E; Camera M
    Thromb Res; 2011 Aug; 128(2):161-8. PubMed ID: 21420725
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of Endothelial and Platelet Derived Microparticles in Patients with Acute Coronary Syndrome.
    George M; Ganesh MR; Sridhar A; Jena A; Rajaram M; Shanmugam E; Dhandapani VE
    J Clin Diagn Res; 2015 Dec; 9(12):OC09-13. PubMed ID: 26816931
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pentraxin 3 as a biomarker for acute coronary syndrome: comparison with biomarkers for cardiac damage.
    Kume N; Mitsuoka H; Hayashida K; Tanaka M
    J Cardiol; 2011 Jul; 58(1):38-45. PubMed ID: 21616640
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Climacteric lowers plasma levels of platelet-derived microparticles: a pilot study in pre- versus postmenopausal women.
    Rank A; Nieuwland R; Roesner S; Nikolajek K; Hiller E; Toth B
    Acta Haematol; 2012; 128(1):53-9. PubMed ID: 22627113
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cell-derived microparticles contain caspase 3 in vitro and in vivo.
    Abid Hussein MN; Nieuwland R; Hau CM; Evers LM; Meesters EW; Sturk A
    J Thromb Haemost; 2005 May; 3(5):888-96. PubMed ID: 15869582
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma signature of apoptotic microvesicles is associated with endothelial dysfunction and plaque rupture in acute coronary syndromes.
    Zacharia E; Antonopoulos AS; Oikonomou E; Papageorgiou N; Pallantza Z; Miliou A; Mystakidi VC; Simantiris S; Kriebardis A; Orologas N; Valasiadi E; Papaioannou S; Galiatsatos N; Antoniades C; Tousoulis D
    J Mol Cell Cardiol; 2020 Jan; 138():110-114. PubMed ID: 31783033
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship between inflammation and benefits of early high-dose rosuvastatin on contrast-induced nephropathy in patients with acute coronary syndrome: the pathophysiological link in the PRATO-ACS study (Protective Effect of Rosuvastatin and Antiplatelet Therapy on Contrast-Induced Nephropathy and Myocardial Damage in Patients With Acute Coronary Syndrome Undergoing Coronary Intervention).
    Toso A; Leoncini M; Maioli M; Tropeano F; Di Vincenzo E; Villani S; Bellandi F
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1421-9. PubMed ID: 25523533
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dissimilarity of increased phosphatidylserine-positive microparticles and associated coagulation activation in acute coronary syndromes.
    Liu Y; He Z; Zhang Y; Dong Z; Bi Y; Kou J; Zhou J; Shi J
    Coron Artery Dis; 2016 Aug; 27(5):365-75. PubMed ID: 27058313
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pentraxin 3, long expression in mononuclear cells of patients with acute coronary syndrome: Correlation with C-reactive protein and matrix metalloproteinase-9 levels.
    Ma R; Zhang W; Wang T; He X; Huang Z; Zhu J; Yao Z
    J Int Med Res; 2014 Jun; 42(3):677-83. PubMed ID: 24709882
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circulating microparticles and the risk of thrombosis in inherited deficiencies of antithrombin, protein C and protein S.
    Campello E; Spiezia L; Radu CM; Bulato C; Gavasso S; Tormene D; Woodhams B; Dalla Valle F; Simioni P
    Thromb Haemost; 2016 Jan; 115(1):81-8. PubMed ID: 26354831
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of a single high loading dose of rosuvastatin on percutaneous coronary intervention for acute coronary syndromes.
    Wang Z; Dai H; Xing M; Yu Z; Lin X; Wang S; Zhang J; Hou F; Ma Y; Ren Y; Tan K; Wang Y; Ge Z
    J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):327-33. PubMed ID: 23364255
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In-hospital free fatty acids levels predict the severity of myocardial ischemia of acute coronary syndrome.
    Ma P; Han L; Lv Z; Chen W; Hu H; Tu J; Zhou X; Liu SM
    BMC Cardiovasc Disord; 2016 Feb; 16():29. PubMed ID: 26830193
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Remote ischemic preconditioning immediately before percutaneous coronary intervention does not impact myocardial necrosis, inflammatory response, and circulating endothelial progenitor cell counts: a single center randomized sham controlled trial.
    Prasad A; Gössl M; Hoyt J; Lennon RJ; Polk L; Simari R; Holmes DR; Rihal CS; Lerman A
    Catheter Cardiovasc Interv; 2013 May; 81(6):930-6. PubMed ID: 22517646
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elevated levels of oxidized low-density lipoprotein correlate positively with C-reactive protein in patients with acute coronary syndrome.
    Zhang YC; Wei JJ; Wang F; Chen MT; Zhang MZ
    Cell Biochem Biophys; 2012 Mar; 62(2):365-72. PubMed ID: 21947962
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The relation between the levels of osteoprotegerin and the degree of coronary artery disease in patients with acute coronary syndrome and stable angina pectoris.
    Aksu F; Ozçelik F; Kunduracilar H; Barutçu A; Yel M; Umit EG; Altun A
    Kardiol Pol; 2014; 72(1):34-41. PubMed ID: 24469748
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical value of plasma pentraxin 3 levels for predicting cardiac troponin elevation after percutaneous coronary intervention.
    Wang Z; Sato A; Akiyama D; Kimura T; Tajiri K; Hoshi T; Sakai S; Koike A; Miyauchi T; Aonuma K
    Life Sci; 2014 Jan; 95(1):40-4. PubMed ID: 24333560
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long pentraxin-3 measured at late phase associated with GRACE risk scores in patients with non-ST elevation acute coronary syndrome and coronary stenting.
    Saygı S; Kırılmaz B; Tengiz İ; Türk UÖ; Yıldız H; Tuzun N; Alioğlu E; Tamer GS; Ercan E
    Turk Kardiyol Dern Ars; 2012 Apr; 40(3):205-12. PubMed ID: 22864315
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antigenic characterization of endothelial cell-derived microparticles and their detection ex vivo.
    Abid Hussein MN; Meesters EW; Osmanovic N; Romijn FP; Nieuwland R; Sturk A
    J Thromb Haemost; 2003 Nov; 1(11):2434-43. PubMed ID: 14629480
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clearance of platelet microparticles in vivo.
    Rank A; Nieuwland R; Crispin A; Grützner S; Iberer M; Toth B; Pihusch R
    Platelets; 2011; 22(2):111-6. PubMed ID: 21231854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.